SCHEMBL23112463

SCHEMBL23112463

CCOC(=O)c1cc(C(=O)OCC)n(CC(=O)c2ccc(Cl)c(Cl)c2)n1

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NOTUM Q6P988 1/20 0.49
MGAM O43451 2/20 0.48
AMY1A P0DUB6 2/20 0.48
GAA P10253 2/20 0.48
SI P14410 2/20 0.48
MGAM2 Q2M2H8 2/20 0.48
ALDH1A1 P00352 3/20 0.43
AGTR1 P30556 3/20 0.43
GABRA2 P47869 1/20 0.43
GABRB2 P47870 1/20 0.43
KDM4E B2RXH2 1/20 0.43
SMN1; SMN2 Q16637 2/20 0.41
POLB P06746 1/20 0.41
RAB9A P51151 3/20 0.41
NPC1 O15118 2/20 0.41
ATM Q13315 2/20 0.41
TSHR P16473 1/20 0.41
P2RY12 Q9H244 1/20 0.40
CYP1A2 P05177 1/20 0.40
CYP3A4 P08684 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29977559 1.00 NOTUM (0.49) NOTUMMGAMAMY1AGAASI
SCHEMBL28542240 0.92 GAA (0.42) NOTUMMGAMAMY1AGAASI
SCHEMBL29977448 0.92 GAA (0.42) NOTUMMGAMAMY1AGAASI
SCHEMBL29977154 0.86 SMN1; SMN2 (0.46) GAAALDH1A1KDM4ESMN1; SMN2POLB
SCHEMBL28560572 0.86 SMN1; SMN2 (0.46) GAAALDH1A1KDM4ESMN1; SMN2POLB
SCHEMBL28546956 0.85 SMN1; SMN2 (0.40) GAAKDM4ESMN1; SMN2POLBRAB9A
SCHEMBL23112275 0.83 HPGD (0.40) GAAALDH1A1AGTR1GABRA2GABRB2
SCHEMBL23112584 0.83 SMN1; SMN2 (0.51) GAAALDH1A1GABRA2GABRB2KDM4E
SCHEMBL23112586 0.83 MAPT (0.41) GAAALDH1A1KDM4ESMN1; SMN2POLB
SCHEMBL29977114 0.83 HPGD (0.40) GAAALDH1A1AGTR1GABRA2GABRB2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20220324865-A1 SUBSTITUTED DIHYDROPYRAZOLO PYRAZINE CARBOXAMIDE DERIVATIVES BAYER PHARMA AKTIENGESELLSCHAFT (DE) 2022-10-13 US disclosed
EP-3793559-A1 SUBSTITUTED DIHYDROPYRAZOLO PYRAZINE CARBOXAMIDE DERIVATIVES Bayer Aktiengesellschaft (DE) 2021-03-24 EP disclosed
CN-112469412-A Substituted dihydropyrazolopyrazine carboxamide derivatives 拜耳公司 2021-03-09 CN disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20220324865-A1 SUBSTITUTED DIHYDROPYRAZOLO PYRAZINE CARBOXAMIDE DERIVATIVES QDPR, SIRT5, PDXK NOTUM 2577/4885MGAM 2303/4885AMY1A 4407/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.